| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |